After the panel presentation, “The Controversial QALY: Is There a Middle Ground in the Debate?” was wrapped up at ISPOR, AJMC deputy editor, Jaime Rosenberg, sat down with IVI’s Jennifer Bright and Lou Garrison (assistant director of the Pharmaceutical Outcomes Research and Policy Program at the University of Washington) to drill down further into the quality-adjusted life-year (QALY).

Listen to the podcast here.